User's Publication |
19808
Yamaguchi I, Katoh H.
Merlin/NF2 regulates SLC7A11/xCT expression and cell viability under glucose deprivation at high cell density in glioblastoma cells
J Biochem
2024
175(3):313-322
PubMed ID: 38102738
DOI: 10.1093/jb/mvad105
|
19869
Morimoto T, Nakazawa T, Maeoka R, Matsuda R, Nakamura M, Nishimura F, Yamada S, Nakagawa I, Park YS, Tsujimura T.
Bulk RNA sequencing reveals the comprehensive genetic characteristics of human cord blood-derived natural killer cells
Regen Ther
2024
25:367-376
PubMed ID: 38405180
DOI: 10.1016/j.reth.2024.02.002
|
21603
Morimoto T, Nakazawa T, Matsuda R, Maeoka R, Nishimura F, Nakamura M, Yamada S, Park YS, Tsujimura T, Nakagawa I.
Antitumor Effects of Intravenous Natural Killer Cell Infusion in an Orthotopic Glioblastoma Xenograft Murine Model and Gene Expression Profile Analysis.
Int J Mol Sci
2024
25(4)
PubMed ID: 38397112
DOI: 10.3390/ijms25042435
|
21638
Koh I, Hagiwara M.
Modular tissue-in-a-CUBE platform to model blood-brain barrier (BBB) and brain interaction.
Commun Biol
2024
7(1):177
PubMed ID: 38418614
DOI: 10.1038/s42003-024-05857-8
|
21674
Kinoshita S, Ishii M, Ando J, Kimura T, Yamaguchi T, Harada S, Takahashi F, Nakashima K, Nakazawa Y, Yamazaki S, Ohshima K, Takahashi K, Nakauchi H, Ando M.
Rejuvenated iPSC-derived GD2-directed CART Cells Harbor Robust Cytotoxicity Against Small Cell Lung Cancer.
Cancer Res Commun
2024
4(3):723-737
PubMed ID: 38380966
DOI: 10.1158/2767-9764.CRC-23-0259
|
19592
Maeoka R, Nakazawa T, Matsuda R, Morimoto T, Shida Y, Yamada S, Nishimura F, Nakamura M, Nakagawa I, Park YS, Tsujimura T, Nakase H.
Therapeutic Anti-KIR Antibody of 1-7F9 Attenuates the Antitumor Effects of Expanded and Activated Human Primary Natural Killer Cells on In Vitro Glioblastoma-like Cells and Orthotopic Tumors Derived Therefrom
Int J Mol Sci
2023
24(18):14183
PubMed ID: 37762486
DOI: 10.3390/ijms241814183
|
19770
Mitobe Y, Suzuki S, Nakagawa-Saito Y, Togashi K, Sugai A, Sonoda Y, Kitanaka C, Okada M.
Antagonizing MDM2 Overexpression Induced by MDM4 Inhibitor CEP-1347 Effectively Reactivates Wild-Type p53 in Malignant Brain Tumor Cells
Cancers (Basel)
2023
15(17):4326
PubMed ID: 37686602
DOI: 10.3390/cancers15174326
|
19946
Nakazawa T, Maeoka R, Morimoto T, Matsuda R, Nakamura M, Nishimura F, Yamada S, Nakagawa I, Park YS, Ito T, Nakase H, Tsujimura T.
An efficient feeder-free and chemically-defined expansion strategy for highly purified natural killer cells derived from human cord blood
Regen Ther
2023
24:32-42
PubMed ID: 37303464
DOI: 10.1016/j.reth.2023.05.006
|
19953
Nakazawa T, Morimoto T, Maeoka R, Matsuda R, Nakamura M, Nishimura F, Ouji N, Yamada S, Nakagawa I, Park YS, Ito T, Nakase H, Tsujimura T.
CIS deletion by CRISPR/Cas9 enhances human primary natural killer cell functions against allogeneic glioblastoma
J Exp Clin Cancer Res
2023
42(1):205
PubMed ID: 37563692
DOI: 10.1186/s13046-023-02770-6
|
21090
Li Y, Matsumoto Y, Chen L, Sugawara Y, Oe E, Fujisawa N, Ebara M, Sakurai H.
Smart Nanofiber Mesh with Locally Sustained Drug Release Enabled Synergistic Combination Therapy for Glioblastoma.
Nanomaterials (Basel)
2023
13(3)
PubMed ID: 36770373
DOI: 10.3390/nano13030414
|
21373
Suzuki MM, Iijima K, Ogami K, Shinjo K, Murofushi Y, Xie J, Wang X, Kitano Y, Mamiya A, Kibe Y, Nishimura T, Ohka F, Saito R, Sato S, Kobayashi J, Yao R, Miyata K, Kataoka K, Suzuki HI, Kondo Y.
TUG1-mediated R-loop resolution at microsatellite loci as a prerequisite for cancer cell proliferation.
Nat Commun
2023
14(1):4521
PubMed ID: 37607907
DOI: 10.1038/s41467-023-40243-8
|
21380
Tagawa Y, Sakagami H, Tanuma SI, Amano S, Uota S, Bandow K, Tomomura M, Uesawa Y, Takao K, Sugita Y, Yamamoto N, Sakashita H, Nakakaji R, Koizumi T, Mitsudo K, Tohnai I.
Potentiation of Anticancer Activity of G2/M Blockers by Mild Hyperthermia.
Anticancer Res
2023
43(8):3429-3439
PubMed ID: 37500171
DOI: 10.21873/anticanres.16518
|
17698
Yuji Doi, Daigo Wakana, Satoshi Kitaoka, Hisashi Takeda, Eiji Tanaka, Tomoo Hosoe
Secalonic Acid and Benzoic Acid Analogues Exhibiting Cyto toxicity against Cancer Cells Isolated from <i>Claviceps yanagawaensis</i>
Advances in Microbiology
2022
12:649-670
DOI: 10.4236/aim.2022.1212045
|
20564
Hayashima K, Katoh H.
Expression of gamma-glutamyltransferase 1 in glioblastoma cells confers resistance to cystine deprivation-induced ferroptosis.
J Biol Chem
2022
101703
PubMed ID: 35148992
DOI: 10.1016/j.jbc.2022.101703
|
20607
Shinohara Y, Ando H, Maekawa M, Arai M, Horibata Y, Satou M, Jojima T, Usui I, Aso Y, Sugimoto H.
Transcription of cytochrome P450 46A1 in NIH3T3 cells is negatively regulated by FBS.
Biochim Biophys Acta Mol Cell Biol Lipids
2022
1867(6):159136
PubMed ID: 35306146
DOI: 10.1016/j.bbalip.2022.159136
|
20874
Mitobe Y, Nakagawa-Saito Y, Togashi K, Suzuki S, Sugai A, Matsuda KI, Sonoda Y, Kitanaka C, Okada M.
CEP-1347 Targets MDM4 Protein Expression to Activate p53 and Inhibit the Growth of Glioma Cells.
Anticancer Res
2022
42(10):4727-4733
PubMed ID: 36192008
DOI: 10.21873/anticanres.15977
|
20884
Shindo A, Kusano M, Sakagami H, Amano S, Inomata M, Abe M, Okazawa M, Ooka T.
Comparison of UVC Sensitivity and Dectin-2 Expression Between Malignant and Non-malignant Cells.
In Vivo
2022
36(5):2116-2125
PubMed ID: 36099100
DOI: 10.21873/invivo.12937
|
13413
Hayashima K, Kimura I, Katoh H.
Role of ferritinophagy in cystine deprivation-induced cell death in glioblastoma cells.
Biochem Biophys Res Commun
2021
PubMed ID: 33421769
DOI: 10.1016/j.bbrc.2020.12.075
|
12121
Yamaguchi I, Yoshimura SH, Katoh H.
High cell density increases glioblastoma cell viability under glucose deprivation via degradation of the cystine/glutamate transporter xCT (SLC7A11).
J. Biol. Chem.
2020
PubMed ID: 32265299
DOI: 10.1074/jbc.RA119.012213
|
12999
Kinashi Y, Ikawa T, Takahashi S.
The combined effect of neutron irradiation and temozolomide on glioblastoma cell lines with different MGMT and P53 status.
Appl Radiat Isot
2020
PubMed ID: 32561044
DOI: 10.1016/j.apradiso.2020.109204
|
11419
Feng S, Cai X, Li Y, Jian X, Zhang L, Li B.
Tripartite motif-containing 14 (TRIM14) promotes epithelial-mesenchymal transition via ZEB2 in glioblastoma cells.
J. Exp. Clin. Cancer Res.
2019
PubMed ID: 30728039
DOI: 10.1186/s13046-019-1070-x
|
4672
Ohka F, Shinjo K, Deguchi S, Matsui Y, Okuno Y, Katsushima K, Suzuki M, Kato A, Ogiso N, Yamamichi A, Aoki K, Suzuki H, Sato S, Arul Rayan N, Prabhakar S, Göke J, Shimamura T, Maruyama R, Takahashi S, Suzumura A, Kimura H, Wakabayashi T, Zong H, Natsume A, Kondo Y.
Pathogenic Epigenetic Consequences of Genetic Alterations in IDH-wild-type Diffuse Astrocytic Gliomas.
Cancer Res
2019
79(19):4814-4827
PubMed ID: 31431463
DOI: 10.1158/0008-5472.CAN-19-1272
|
11505
Kageyama-Yahara N, Yamamichi N, Takahashi Y, Takeuchi C, Matsumoto Y, Sakaguchi Y, Koike K.
Tandem repeats of the 5' flanking region of human MUC5AC have a role as a novel enhancer in MUC5AC gene expression.
Biochem Biophys Rep
2019
18:100632
PubMed ID: 30993217
DOI: 10.1016/j.bbrep.2019.100632
|
6953
Imaeda A, Tomoike F, Hayakawa M, Nakamoto K, Kimura Y, Abe N, Abe H.
N6-methyl adenosine in siRNA evades immune response without reducing RNAi activity.
Nucleosides Nucleotides Nucleic Acids
2019
38(12):972-979
PubMed ID: 31298608
DOI: 10.1080/15257770.2019.1641205
|
12144
Ranjit M, Hirano M, Aoki K, Okuno Y, Ohka F, Yamamichi A, Kato A, Maeda S, Motomura K, Matsuo K, Enomoto A, Ino Y, Todo T, Takahashi M, Wakabayashi T, Kato T, Natsume A.
Aberrant Active cis-Regulatory Elements Associated with Downregulation of RET Finger Protein Overcome Chemoresistance in Glioblastoma
Cell Rep
2019
2274-2281.e5
PubMed ID: 30811978
DOI: 10.1016/j.celrep.2019.01.109
|
12593
Qiu W, Song S, Chen W, Zhang J, Yang H, Chen Y.
Hypoxia-induced EPHB2 promotes invasive potential of glioblastoma
Int J Clin Exp Pathol
2019
12(2):539-548
PubMed ID: 31933858
|
14811
Fan L, Chen Z, Wu X, Cai X, Feng S, Lu J, Wang H, Liu N.
Ubiquitin-Specific Protease 3 Promotes Glioblastoma Cell Invasion and Epithelial-Mesenchymal Transition via Stabilizing Snail
Mol Cancer Res
2019
17(10):1975-1984
PubMed ID: 31266817
DOI: 10.1158/1541-7786.MCR-19-0197
|
4353
Peng F, Wang X, Shu M, Yang M, Wang L, Ouyang Z, Shen C, Hou X, Zhao B, Wang X, Zhang LW, Liu Y, Zhao S.
Raddeanin a Suppresses Glioblastoma Growth by Inducing ROS Generation and Subsequent JNK Activation to Promote Cell Apoptosis.
Cell. Physiol. Biochem.
2018
47(3):1108-1121
PubMed ID: 29843152
DOI: 10.1159/000490187
|
4375
Fukushima T, Kawaguchi M, Yamamoto K, Yamashita F, Izumi A, Kaieda T, Takezaki Y, Itoh H, Takeshima H, Kataoka H.
Aberrant methylation and silencing of the SPINT2 gene in high-grade gliomas.
Cancer Sci.
2018
109(9):2970-2979
PubMed ID: 29987920
DOI: 10.1111/cas.13732
|
4503
Ishiguro Y, Kobayashi M, Ideno M, Narumi K, Furugen A, Iseki K.
Valproate sensitizes human glioblastoma cells to 3-bromopyruvate-induced cytotoxicity.
Int J Pharm
2018
551(1-2):97-102
PubMed ID: 30138705
DOI: 10.1016/j.ijpharm.2018.08.039
|
14903
Zhao B, Shen C, Zheng Z, Wang X, Zhao W, Chen X, Peng F, Xue L, Shu M, Hou X, Wang K, Zhong C, Sun J, Wan J, Zhao S.
Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking
Cell Physiol Biochem
2018
51(4):1566-1583
PubMed ID: 30497066
DOI: 10.1159/000495646
|
10052
Shinoda Y, Takahashi T, Akimoto J, Ichikawa M, Yamazaki H, Narumi A, Yano S, Fujiwara Y.
Comparative photodynamic therapy cytotoxicity of mannose-conjugated chlorin and talaporfin sodium in cultured human and rat cells.
J Toxicol Sci
2017
42:111-119
PubMed ID: 28070104
DOI: 10.2131/jts.42.111
|
10112
Asano M, Sakaguchi M, Tanaka S, Kashimura K, Mitani T, Kawase M, Matsumura H, Yamaguchi T, Fujita Y, Tabuse K.
Effects of Normothermic Conditioned Microwave Irradiation on Cultured Cells Using an Irradiation System with Semiconductor Oscillator and Thermo-regulatory Applicator.
Sci Rep
2017
7:41244
PubMed ID: 28145466
DOI: 10.1038/srep41244
|
10523
Asano M, Tanaka S, Sakaguchi M, Matsumura H, Yamaguchi T, Fujita Y, Tabuse K.
Normothermic Microwave Irradiation Induces Death of HL-60 Cells through Heat-Independent Apoptosis.
Sci Rep
2017
7:11406
PubMed ID: 28900243
DOI: 10.1038/s41598-017-11784-y
|
10559
Goji T, Takahara K, Negishi M, Katoh H.
Cystine uptake through the cystine/glutamate antiporter xCT triggers glioblastoma cell death under glucose deprivation.
J. Biol. Chem.
2017
292:19721-19732
PubMed ID: 29038291
DOI: 10.1074/jbc.M117.814392
|
5680
Ginting TE, Suryatenggara J, Christian S, Mathew G.
Proinflammatory response induced by Newcastle disease virus in tumor and normal cells.
Oncolytic Virother
2017
6:21-30
PubMed ID: 28293547
DOI: 10.2147/OV.S123292
|
14208
Miyata K, Takemoto A, Okumura S, Nishio M, Fujita N.
Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregation
Sci Rep
2017
7(1):4059
PubMed ID: 28642617
DOI: 10.1038/s41598-017-04324-1
|
18189
Peng C, Chen Z, Wang S, Wang HW, Qiu W, Zhao L, Xu R, Luo H, Chen Y, Chen D, You Y, Liu N, Wang H.
The Error-Prone DNA Polymerase κ Promotes Temozolomide Resistance in Glioblastoma through Rad17-Dependent Activation of ATR-Chk1 Signaling
Cancer Res
2016
76(8):2340-53
PubMed ID: 26960975
DOI: 10.1158/0008-5472.CAN-15-1884
|
7299
Miki Y, Akimoto J, Moritake K, Hironaka C, Fujiwara Y.
Photodynamic therapy using talaporfin sodium induces concentration-dependent programmed necroptosis in human glioblastoma T98G cells.
Lasers Med Sci
2015
30:1739-45
PubMed ID: 26109138
DOI: 10.1007/s10103-015-1783-9
|
7547
Miki Y., Akimoto J., Sato A., Fujiwara Y.
Evaluation of laser irradiance on photodynamic therapy using talaporfin sodium-induced glioblastoma T98G cell death.
Fundamental Toxicological Sciences
2015
2:111-116
DOI: 10.2131/fts.2.111
|
7557
Seki K, Kinashi Y, Takahashi S.
Influence of p53 status on the effects of boron neutron capture therapy in glioblastoma.
Anticancer Res.
2015
35:169-74
PubMed ID: 25550548
|
15122
Liu H, Li C, Shen C, Yin F, Wang K, Liu Y, Zheng B, Zhang W, Hou X, Chen X, Wu J, Wang X, Zhong C, Zhang J, Shi H, Ai J, Zhao S.
MiR-212-3p inhibits glioblastoma cell proliferation by targeting SGK3
J Neurooncol
2015
122(3):431-9
PubMed ID: 25720694
DOI: 10.1007/s11060-015-1736-y
|
15156
Hirohara S, Oka C, Totani M, Obata M, Yuasa J, Ito H, Tamura M, Matsui H, Kakiuchi K, Kawai T, Kawaichi M, Tanihara M.
Synthesis, Photophysical Properties, and Biological Evaluation of trans-Bisthioglycosylated Tetrakis(fluorophenyl)chlorin for Photodynamic Therapy
J Med Chem
2015
58(21):8658-70
PubMed ID: 26457363
DOI: 10.1021/acs.jmedchem.5b01262
|
15102
Sasaki S, Futagi Y, Kobayashi M, Ogura J, Iseki K.
Functional characterization of 5-oxoproline transport via SLC16A1/MCT1
J Biol Chem
2015
290(4):2303-11
PubMed ID: 25371203
DOI: 10.1074/jbc.M114.581892
|
17085
Kinashi Y, Okumura K, Kubota Y, Kitajima E, Okayasu R, Ono K, Takahashi S.
Dose-rate effect was observed in T98G glioma cells following BNCT
Appl Radiat Isot
2014
88:81-5
PubMed ID: 24360864
DOI: 10.1016/j.apradiso.2013.11.117
|
19076
Zhao SG, Chen XF, Wang LG, Yang G, Han DY, Teng L, Yang MC, Wang DY, Shi C, Liu YH, Zheng BJ, Shi CB, Gao X, Rainov NG.
Increased expression of ABCB6 enhances protoporphyrin IX accumulation and photodynamic effect in human glioma
Ann Surg Oncol
2013
20(13):4379-88
PubMed ID: 22688660
DOI: 10.1245/s10434-011-2201-6
|
13710
Fukushima T, Kawaguchi M, Yorita K, Tanaka H, Takeshima H, Umezawa K, Kataoka H.
Antitumor effect of dehydroxymethylepoxyquinomicin, a small molecule inhibitor of nuclear factor-κB, on glioblastoma
Neuro Oncol
2012
14(1):19-28
PubMed ID: 21968049
DOI: 10.1093/neuonc/nor168
|
15728
Matsuda K, Sato A, Okada M, Shibuya K, Seino S, Suzuki K, Watanabe E, Narita Y, Shibui S, Kayama T, Kitanaka C.
Targeting JNK for therapeutic depletion of stem-like glioblastoma cells
Sci Rep
2012
2:516
PubMed ID: 22816039
DOI: 10.1038/srep00516
|
6312
Ohsaka, Y. & Nishino, H.
Normal Japanese individuals harbor polymorphisms in the p14 ARF /INK4 locus promoters and/or other gene introns. — Variation in nucleotide sequences in each individual
Genes Genom
2011
33: 621
DOI: 10.1007/s13258-011-0085-2
|
7797
Ohsaka Y, Nishino H.
Polymorphisms in promoter sequences of MDM2, p53, and p16 genes in normal Japanese individuals.
Genet. Mol. Biol.
2010
33:615-26
PubMed ID: 21637567
DOI: 10.1590/s1415-47572010000400004
|
7905
Tomiyama A, Tachibana K, Suzuki K, Seino S, Sunayama J, Matsuda KI, Sato A, Matsumoto Y, Nomiya T, Nemoto K, Yamashita H, Kayama T, Ando K, Kitanaka C.
MEK-ERK-dependent multiple caspase activation by mitochondrial proapoptotic Bcl-2 family proteins is essential for heavy ion irradiation-induced glioma cell death.
Cell Death Dis
2010
1:e60
PubMed ID: 21364665
DOI: 10.1038/cddis.2010.37
|
8109
Ohsaka Y, Yogosawa S, Nakanishi R, Sakai T, Nishino H.
Polymorphisms in promoter sequences of the p15 ( INK4B ) and PTEN genes of normal Japanese individuals.
Biochem. Genet.
2010
48:970-86
PubMed ID: 20862607
DOI: 10.1007/s10528-010-9379-3
|
16551
Song X, Chen Z, Wu C, Zhao S.
Abrogating HSP response augments cell death induced by As2O3 in glioma cell lines
Can J Neurol Sci
2010
37(4):504-11
PubMed ID: 20724260
DOI: 10.1017/s0317167100010544
|
18304
Zhao S, Zhang J, Zhang X, Dong X, Sun X.
Arsenic trioxide induces different gene expression profiles of genes related to growth and apoptosis in glioma cells dependent on the p53 status
Mol Biol Rep
2008
35(3):421-9
PubMed ID: 17530438
DOI: 10.1007/s11033-007-9102-6
|
3698
Fukushima T, Tezuka T, Shimomura T, Nakano S, Kataoka H.
Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24.
J Biol Chem
2007
282(25):18634-44
PubMed ID: 17475624
DOI: 10.1074/jbc.M609567200
|
18714
Genkai N, Homma J, Sano M, Tanaka R, Yamanaka R.
Increased expression of pituitary tumor-transforming gene (PTTG)-1 is correlated with poor prognosis in glioma patients
Oncol Rep
2006
15(6):1569-74
PubMed ID: 16685397
|
14417
Sano M, Genkai N, Yajima N, Tsuchiya N, Homma J, Tanaka R, Miki T, Yamanaka R.
Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients
Oncol Rep
2006
16(5):1093-8
PubMed ID: 17016598
|
14418
Homma J, Yamanaka R, Yajima N, Tsuchiya N, Genkai N, Sano M, Tanaka R.
Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients
Oncol Rep
2006
15(3):595-601
PubMed ID: 16465418
|